Amgen’s COVID-19 manufacturing deal with Lilly helped compensate for lagging Aimovig, Enbrel in Q4

Amgen’s COVID-19 manufacturing deal with Lilly helped compensate for lagging Aimovig, Enbrel in Q4
kdunleavy
Mon, 02/07/2022 – 17:42